On Jan. 28, 2021, OraSure Technologies announced its OMNIgene®·ORAL (OME-505) saliva collection device, a product of Ottawa-based subsidiary…
On Jan. 27, 2021, a U.S. Centers for Disease Control and Prevention (CDC) study found that the 2019-2020…
On Jan. 27, 2021, Vaxart announced that health care economic findings published in the American Journal of Preventative…
On Jan. 27, 2021, OncoSec Medical announced that it had dosed several subjects in its Phase 1 clinical…
On Jan. 27, 2021, Eli Lilly, Vir Biotechnology and GlaxoSmithKline announced a collaboration to evaluate a combination of…
On Jan. 27, 2021, Moderna confirmed that the Company is in discussion with the U.S. government to purchase…
On Jan. 27, 2021, researchers at the Broad Institute of MIT and Harvard, and Massachusetts General Hospital’s Center…
On Jan. 27, 2021, researchers in Dr. David Ho’s Columbia University lab and Regeneron scientists announced they had…
On Jan. 27, 2021, Pfizer and BioNTech announced results from in vitro neutralization studies of sera from individuals…
On Jan. 27, 2021, Evotec announced that the U.S. Department of Defense (DOD) awarded its Seattle, Washington-based subsidiary,…
On Jan. 26, 2021, NIH researchers announced that an investigational anti-HIV antibody delivered intravenously once every eight weeks…
On Jan. 26, 2021, Abbott announced it had received CE Mark for two new uses of its Panbioﾙ…
On Jan. 26, 2021, NIH researchers announced that a new database to collect information from clinicians about COVID-19-related…
On Jan. 26, 2021, WHO recommends that patients who have COVID-19 – both confirmed and suspected – should…
On Jan. 26, 2021, Vaxart announced additional results from its SARS-CoV-2 Hamster Challenge Study, as well as a…
On Jan. 26, 2021, Sorrento Therapeutics announced positive preliminary results from its Phase 1b study of human allogeneic…
On Jan. 26, 2021, Eli Lilly announced that bamlanivimab (LY-CoV555) 2800 mg and etesevimab (LY-CoV016) 2800 mg together…
On Jan. 26, 2021, Moderna reported that 30.4 million doses have been supplied to the U.S. Government to…
On Jan. 26, 2021, Regeneron announced positive initial results from an ongoing Phase 3 clinical trial evaluating REGEN-COV…
On Jan. 26, 2021, BioReference Laboratories, an OPKO Health company, announced COVID-19 testing agreements for players and officials,…
On Jan. 26, 2021, OraSure Technologies announced that Chronomics had selected the OMNIgene-ORAL (OME-505) saliva collection device as…
On Jan. 25, 2021, Merck announced that the company had discontinued development of its SARS-CoV-2/COVID-19 vaccine candidates, V590…
On Jan. 25, 2021, Medigen Vaccine Biologics and Dynavax Technologies announced that the first participant had been dosed…
On Jan. 25, 2021, HHMI investigators reported that cholesterol, the waxy compound better known for clogging arteries, helps…
On Jan. 25, 2021, the National Institutes of Health (NIH) announced that in large clinical trial conducted worldwide,…
On Jan. 25, 2021, scientists at the University of Oxford reported that after reviewing interim analyses of both…
On Jan. 25, 2021, Mateon Therapeutics announced that it was launching its mobile app, ARTIHealthTM, for respiratory health…
On Jan. 25, 2021, Nirmidas Biotech announced its second FDA Emergency Use Authorization (EUA) for their COVID-19 rapid…
On Jan. 25, 2021, Moderna announced results from in vitro neutralization studies of sera from individuals vaccinated with…
On Jan. 25, 2021, BD (Becton, Dickinson) announced the publication of a peer-reviewed study that showed BD’s antigen…